Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAHONEY DAVID L −$12.3M Director sold 8% of stake
  2. Maduck Sean −$11.7M See Remarks sold 91% of stake
  3. Vieira Roberto Wandenkolk −$8.1M President, Oncology sold 95% of stake
  4. Park Kimberly −$3.3M Director sold 100% of stake
  5. Lyon Joseph Douglas −$2.3M See Remarks sold 78% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-17 Robb Gary Charles Chief Business Officer Option exercise · Stock option (right to buy) −17,493 182,507
2026-09-16 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −296 $100.82 $30K 3,946
2026-09-15 WILSON JAMES N Director Sale 10b5-1 −6,800 $110.27 $750K 1,067,743
2026-09-15 WILSON JAMES N Director Sale 10b5-1 −400 $110.84 $44K 1,067,343
2026-09-15 WILSON JAMES N Director Sale 10b5-1 −2,800 $111.70 $313K 1,064,543
2026-09-14 Lyon Joseph Douglas See Remarks Option exercise 10b5-1 +2,596 $11.35 $29K 8,279
2026-09-14 Lyon Joseph Douglas See Remarks Option exercise 10b5-1 +7,404 $13.56 $100K 15,683
2026-09-14 Lyon Joseph Douglas See Remarks Sale 10b5-1 −7,812 $113.32 $885K 7,871
2026-09-14 Lyon Joseph Douglas See Remarks Sale 10b5-1 −2,188 $114.12 $250K 5,683
2026-09-14 Lyon Joseph Douglas See Remarks Option exercise · Stock option (right to buy) 10b5-1 −2,596 0
2026-09-14 Lyon Joseph Douglas See Remarks Option exercise · Stock option (right to buy) 10b5-1 −7,404 4,167
2026-09-02 Maduck Sean See Remarks Shares withheld for taxes 10b5-1 −117 $113.38 $13K 9,938
2026-09-02 Mokari Atabak Chief Financial Officer Shares withheld for taxes −102 $113.38 $12K 16,304
2026-09-02 Robb Gary Charles Chief Business Officer Shares withheld for taxes −91 $113.38 $10K 13,663
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Shares withheld for taxes 10b5-1 −102 $113.38 $12K 4,242
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Option exercise 10b5-1 +58,333 $21.63 $1.3M 62,575
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −23,600 $109.35 $2.6M 38,975
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −23,770 $110.70 $2.6M 15,205
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −1,537 $111.37 $171K 13,668
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −974 $112.40 $109K 12,694

Page 3 of 50 · 995 trades